On May 19, the Senate Appropriations Committee approved its Fiscal Year (FY) 2017 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations bill. The Senate bill would give FDA $2.760 billion in FY 2017 for salaries and expenses. This is $39 million more than FDA received in FY 2016, $29 million more than the president’s Budget Request, and $6 million more than the House version of the bill. The Senate proposes increases of $2 million for precision medicine; $1 million to evaluate biomarkers for drug development; and $1 million for medical device post-market safety activities. ACT-AD had called for a figure of $2.85 billion, but we will advocate for the Senate number when the House and Senate versions of the appropriations bills advance this year. Read more about the Senate bill here.